Black Diamond Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -27 | -66 | -86 | |
EBITDA | -9,009 | -10,196 | -8,412 | -10,475 |
EBIT | -9,036 | -10,262 | -8,498 | -10,561 |
Net Income | -9,036 | -15,116 | -8,498 | -10,561 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,232 | -6,787 | -7,850 | -9,159 |
Cash | 30,071 | 20,990 | 30,864 | 29,993 |
Basic Shares | 57,233 | 57,090 | 56,929 | 56,803 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $70,000 | $0 | $0 | $0 |
Gross Profit | 69,675 | -343 | -437 | -3,238 |
EBITDA | 22,692 | -69,333 | -82,005 | -90,661 |
EBIT | 22,367 | -69,676 | -82,442 | -91,169 |
Net Income | 22,367 | -69,676 | -82,442 | -91,169 |
Net Change In Cash | 70,000 | 0 | 0 | 0 |
Cost of Revenue | -31,539 | |||
Free Cash Flow | 29,614 | -62,303 | -66,750 | -85,274 |
Cash | 20,990 | 36,437 | 56,221 | 34,315 |
Basic Shares | 57,562 | 55,028 | 43,954 | 36,229 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.16 |
2025-12-31 | -$0.13 |
2025-09-30 | -$0.15 |
2025-06-30 | -$0.19 |